Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;33(4):e68.
doi: 10.3802/jgo.2022.33.e68.

Turning up the heat does not affect quality of life

Willemien J van Driel  1 , S Lot Aronson  2   3 , Ruby M van Stein  2 , Gabe S Sonke  3
Affiliations
Editorial

Turning up the heat does not affect quality of life

Willemien J van Driel et al. J Gynecol Oncol. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Sonke reports receiving institutional research support from Agendia, AstraZeneca, Merck, Novartis, Roche and, Seagen outside the scope of this review. The other authors report no conflict of interest.

Comment on

References

    1. Lim MC, Chang SJ, Park B, Yoo HJ, Yoo CW, Nam BH, et al. Survival after hyperthermic intraperitoneal chemotherapy and primary or interval cytoreductive surgery in ovarian cancer: a randomized clinical trial. JAMA Surg. 2022;157:374–383. - PMC - PubMed
    1. van Driel WJ, Koole SN, Sikorska K, Schagen van Leeuwen JH, Schreuder HW, Hermans RH, et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer. N Engl J Med. 2018;378:230–240. - PubMed
    1. Kim JH, Lee D, Lee Y, Ha HI, Chang YJ, Chang SJ, et al. Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01) J Gynecol Oncol. 2022;33:e54. - PMC - PubMed
    1. Koole SN, Kieffer JM, K Sikorska, Schagen van Leeuwen JH, Schreuder HW, Hermans RH, et al. Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer. Eur J Surg Oncol. 2021;47:101–107. - PubMed